459836-30-7 | [[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl]phosphonic acid

Packsize	Purity	Availability	Price	Discounted Price
1mg	98%	in stock	$138.00	$96.00
2mg	98%	in stock	$178.00	$124.00
5mg	98%	in stock	$230.00	$161.00
10mg	98%	in stock	$343.00	$240.00
25mg	98%	in stock	$582.00	$407.00
100mg	98%	in stock	$2,100.00	$1,470.00

Description

• Catalog Number: AB56263
• Chemical Name: [[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl]phosphonic acid
• CAS Number: 459836-30-7
• Molecular Formula: C17H17BrN3O5P
• Molecular Weight: 454.21174099999996
• MDL Number: MFCD16628139
• SMILES: Brc1ccc(cc1)[C@@H](NC(P(=O)(O)O)c1cccc2c1[nH]c(=O)c(=O)[nH]2)C

Computed Properties

• Complexity: 622
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 1
• Heavy Atom Count: 27
• Hydrogen Bond Acceptor Count: 6
• Hydrogen Bond Donor Count: 5
• Rotatable Bond Count: 5
• Undefined Atom Stereocenter Count: 1
• XLogP3: -1.6

Literature

• Ifenprodil, a NR2B-selective antagonist of NMDA receptor, inhibits reverse Na+/Ca2+ exchanger in neurons.

  Neuropharmacology 20121101

• State-dependent increase of cortical gamma activity during REM sleep after selective blockade of NR2B subunit containing NMDA receptors.

  Sleep 20120701

• NMDARs mediate the role of monoamine oxidase A in pathological aggression.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20120620

• Hippocampus versus entorhinal cortex decoupling by an NR2 subunit-specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy.

  Epilepsia 20120501

• NMDA GluN2A and GluN2B receptors play separate roles in the induction of LTP and LTD in the amygdala and in the acquisition and extinction of conditioned fear.

  Neuropharmacology 20120201

• Role of GluN2A and GluN2B subunits in the formation of filopodia and secondary dendrites in cultured hippocampal neurons.

  Naunyn-Schmiedeberg's archives of pharmacology 20120201

• Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.

  Cell calcium 20120201

• Dopamine induces a GluN2A-dependent form of long-term depression of NMDA synaptic responses in the nucleus accumbens.

  Neuropharmacology 20110501

• Blockade of NR2A-containing NMDA receptors induces Tau phosphorylation in rat hippocampal slices.

  Neural plasticity 20100101

• Differential role of N-methyl-D-aspartate receptor subunits 2A and 2B in mediating phencyclidine-induced perinatal neuronal apoptosis and behavioral deficits.

  Neuroscience 20091110

• Reduced spatial learning in mice treated with NVP-AAM077 through down-regulating neurogenesis.

  European journal of pharmacology 20091110

• N-methyl-D-aspartate-evoked adenosine and inosine release from neurons requires extracellular calcium.

  Canadian journal of physiology and pharmacology 20091001

• Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance.

  Stroke 20081101

• NMDA receptor antagonists reveal age-dependent differences in the properties of visual cortical plasticity.

  Journal of neurophysiology 20081001

• Conditioning-strength dependent involvement of NMDA NR2B subtype receptor in the basolateral nucleus of amygdala in acquisition of auditory fear memory.

  Neuropharmacology 20080801

• Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism.

  Journal of neurochemistry 20080701

• Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test.

  Learning & memory (Cold Spring Harbor, N.Y.) 20080201

• Brain-derived neurotrophic factor activation of extracellular signal-regulated kinase is autonomous from the dominant extrasynaptic NMDA receptor extracellular signal-regulated kinase shutoff pathway.

  Neuroscience 20080124

• Excitotoxicity in vitro by NR2A- and NR2B-containing NMDA receptors.

  Neuropharmacology 20070701

• Modular competition driven by NMDA receptor subtypes in spike-timing-dependent plasticity.

  Journal of neurophysiology 20070401

• Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus.

  Neuropharmacology 20070101

• Pharmacological isolation of postsynaptic currents mediated by NR2A- and NR2B-containing NMDA receptors in the anterior cingulate cortex.

  Molecular pain 20070101

• Effects of exercise on NMDA receptor subunit contributions to bidirectional synaptic plasticity in the mouse dentate gyrus.

  Hippocampus 20070101

• Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.

  Molecular pharmacology 20060901

• Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20060705

• Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20060315

• Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine.

  Neuron 20060216

• Relating NMDA receptor function to receptor subunit composition: limitations of the pharmacological approach.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20060201

• Tonic facilitation of glutamate release by presynaptic NR2B-containing NMDA receptors is increased in the entorhinal cortex of chronically epileptic rats.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20060111

• Contribution of NR2A and NR2B NMDA subunits to bidirectional synaptic plasticity in the hippocampus in vivo.

  Hippocampus 20060101

• Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory.

  Neuron 20050915

• Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20050720

• Roles of NMDA receptor NR2A and NR2B subtypes for long-term depression in the anterior cingulate cortex.

  The European journal of neuroscience 20050701

• Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists.

  Journal of medicinal chemistry 20050407

• Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D: -aspartate receptors in hippocampal slices.

  Experimental brain research 20050401

• Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20040908

• Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid.

  British journal of pharmacology 20040201

• 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition.

  Bioorganic & medicinal chemistry letters 20020408

• Glucocorticoid rapidly enhances NMDA-evoked neurotoxicity by attenuating the NR2A-containing NMDA receptor-mediated ERK1/2 activation.

  Molecular endocrinology (Baltimore, Md.)